| The Company |
GeneralApplied Spectral Imaging (ASI) makes patient care better through advanced biomedical imaging.
ASI’s GenASIs Automated Imaging Platforms for Genetic and Pathological Analysis are the foundation of ASI’s offering. With superior imaging and analysis capabilities, ASI provides state of the art diagnostic aids, offering cytogeneticists and pathologists accurate analysis. GenASIs enables automated tissue analysis for primary diagnostics, with reproducible and reliable results. GenASIs Hyperspectral with HiSKY® Probes adds a new dimension to biomedical image analysis.
GenASIs is FDA cleared for FISH clinical applications such as ALK, UroVysion, HER2/neu, CEP XY and Karyotyping. ASI complies with major regulatory requirements and international quality standards.
ASI is the industry's leading microscopy imaging solution provider since 1993, with over 30 registered patents in the US, Europe and Japan and over 2,500 systems deployed worldwide. With worldwide offices in the US, Europe and Asia, ASI has built a global network of over 50 distributors. The company products are geared towards cancer, pre-, and post-natal diagnosis in clinical and research use. Products range from the basic manual operation mounted on existing laboratory microscopes all the way to fully automatic operation: slide manipulation, scanned acquisition and automatic analysis.
Company CredoApplied Spectral Imaging is committed to excellence and accuracy while remaining a leader in cutting edge technology for cytogenetic and pathology diagnosis. It is dedicated to maintain a supportive environment for laboratory staff: physicians, technologists, and technicians.
ASI’s full capabilities support fluorescent, transmission (Bright-field) and spectral image acquisition, harnessed to genetic tests (karyotyping, FISH, CGH), cytology (cells) and other pathology (tissues) tests. The provided automatic aid and diagnostic tools are all interconnected through a single laboratory communication network to allow team work, supervision, peer review and paperless environment.
Core Technology and Intellectual PropertiesThe company owns 20 patents in the US alone, and other patents in Europe and Japan. These patents cover general use spectral imaging, image analysis, scanning techniques, spectroscopy in life science and medicine and patents for specific applications. |
Follow us:
